Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expert opinion on NSCLC small specimen biomarker testing — Part 2: Analysis, reporting, and quality assessment
Authors
Keywords
-
Journal
VIRCHOWS ARCHIV
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-20
DOI
10.1007/s00428-022-03344-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expert opinion on NSCLC small specimen biomarker testing — Part 1: Tissue collection and management
- (2022) Frédérique Penault-Llorca et al. VIRCHOWS ARCHIV
- ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research
- (2021) C. Belli et al. ANNALS OF ONCOLOGY
- The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
- (2021) Anja Irmisch et al. CANCER CELL
- Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation
- (2021) Carina Heydt et al. BMC Medical Genomics
- RET FISH analysis is a sensitive but highly unspecific screening method for RET fusions in lung cancer
- (2021) Teodora Radonic et al. Journal of Thoracic Oncology
- Lung Cancer in the Netherlands
- (2021) Lizza E.L. Hendriks et al. Journal of Thoracic Oncology
- Making the Most of Complexity to Create Opportunities: Comprehensive Genomic Profiling and Molecular Tumor Board for Patients with Non-Small Cell Lung Cancer (NSCLC)
- (2021) Caterina Fumagalli et al. Cancers
- Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis
- (2021) Yang Liu et al. Translational Lung Cancer Research
- Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA
- (2021) C.M. Della Corte et al. ESMO Open
- Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom
- (2021) Jason Lester et al. BMC CANCER
- Next generation sequencing in cytology
- (2021) Pasquale Pisapia et al. CYTOPATHOLOGY
- The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
- (2021) Keith M. Kerr et al. LUNG CANCER
- A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
- (2021) Matthew H. Larson et al. Nature Communications
- The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
- (2021) Daniel Di Capua et al. Cancers
- The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies
- (2021) A. Russo et al. ESMO Open
- Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study
- (2021) Pasquale Pisapia et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
- (2021) Christian Rolfo et al. Journal of Thoracic Oncology
- The impact of tumor board on cancer care: evidence from an umbrella review
- (2020) Maria Lucia Specchia et al. BMC HEALTH SERVICES RESEARCH
- Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
- (2020) Fränce Hardtstock et al. BMC CANCER
- A model comparing the value of broad next-gen sequencing (NGS)-based testing to single gene testing (SGT) in patients with nonsquamous non-small cell lung cancer (NSCLC) in the United States.
- (2020) Nathan A. Pennell et al. JOURNAL OF CLINICAL ONCOLOGY
- External Quality Assessment Schemes for Biomarker Testing in Oncology
- (2020) Kaat Van Casteren et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)
- (2020) Emma J. de Ruiter et al. MODERN PATHOLOGY
- Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
- (2020) David Tamborero et al. NATURE MEDICINE
- Lung cancer biomarker testing: perspective from Europe
- (2020) Erik Thunnissen et al. Translational Lung Cancer Research
- Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review
- (2020) Rossella Bruno et al. Diagnostics
- Outcomes According to ALK Status Determined by Central IHC or FISH in Patients with ALK-Positive NSCLC Enrolled in the Phase III ALEX Study
- (2020) Tony Mok et al. Journal of Thoracic Oncology
- How current assay approval policies are leading to unintended imprecision medicine
- (2020) Roberto Salgado et al. LANCET ONCOLOGY
- Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL
- (2020) K. Dufraing et al. VIRCHOWS ARCHIV
- Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
- (2019) Annelieke E. C. A. B. Willemsen et al. BRITISH JOURNAL OF CANCER
- Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis
- (2019) Aaron C. Tan et al. LUNG CANCER
- Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
- (2018) Y S Li et al. ANNALS OF ONCOLOGY
- Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma
- (2018) Lavinia Tan et al. INTERNAL MEDICINE JOURNAL
- Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
- (2018) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma—a single center retrospective study
- (2018) Nadezda P. Velizheva et al. PATHOLOGY RESEARCH AND PRACTICE
- A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer
- (2018) Cleo Keppens et al. Oncotarget
- A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
- (2018) J Mateo et al. ANNALS OF ONCOLOGY
- International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
- (2018) Cleo Keppens et al. BMC CANCER
- How to Validate Predictive Immunohistochemistry Testing in Pathology? A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non–Small Cell Lung Cancer
- (2018) Erik Thunnissen ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
- (2017) Marilyn M. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The ins and outs of molecular pathology reporting
- (2017) Véronique Tack et al. VIRCHOWS ARCHIV
- Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non–Small-Cell Lung Cancer
- (2017) David M. Jackman et al. Journal of Oncology Practice
- A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
- (2016) Karen L. Reckamp et al. Journal of Thoracic Oncology
- Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group
- (2015) Manfred Dietel et al. THORAX
- Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel
- (2013) Aldo Scarpa et al. PLoS One
- Development of a Virtual Multidisciplinary Lung Cancer Tumor Board in a Community Setting
- (2013) Marvaretta M. Stevenson et al. Journal of Oncology Practice
- Nucleic acid quantity and quality from paraffin blocks: Defining optimal fixation, processing and DNA/RNA extraction techniques
- (2011) Gulisa Turashvili et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More